Video | 08 February 2019 TB survivors challenge J&J's patent on TB drug in India TUBERCULOSIS India Phumeza and Nandita suffered permanent hearing loss because of toxic drugs used to treat their drug-resistant TB. Now they’re working to ensure that this doesn’t happen to anyone else. Read, watch, share Filter by - Any -ExplainerFeature storyIssue briefLetterNewsletterPhoto storyPress releaseReportResearch articleSpeechStatementVideo Photo credit: MSF/Alexandra Sadokova Press release Press release | 26 April 2023 Tuberculosis MSF demands J&J give up its patent monopoly on TB drug to put lives over profits 5 min Photograph by Atul Loke Press release Press release | 23 March 2023 Tuberculosis India MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend monopoly on lifesaving TB drug 4 min Photo credit: MSF/Alexandra Sadokova Press release Press release | 16 January 2023 Tuberculosis India India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline 4 min Photograph by Oksana Parafeniuk Press release Press release | 15 December 2022 Tuberculosis MSF responds to groundbreaking updated WHO guidelines for drug-resistant tuberculosis 3 min Photograph by Amelia Freelander Press release Press release | 03 May 2022 Tuberculosis MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multidrug-resistant TB 5 min Photograph by Omar Rashid Research article Research article | 19 April 2022 Tuberculosis BMJ Global Health: Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study 2 min Photograph by Atul Loke Press release Press release | 03 September 2021 Tuberculosis Lifesaving TB medicines must be affordable and available to make all-oral treatments for children a reality 4 min Photograph by Atul Loke Press release Press release | 20 April 2021 Tuberculosis MSF supports TB survivors’ court case for Indian government to override patents on lifesaving TB drugs 7 min Load More
Photo credit: MSF/Alexandra Sadokova Press release Press release | 26 April 2023 Tuberculosis MSF demands J&J give up its patent monopoly on TB drug to put lives over profits 5 min
Photograph by Atul Loke Press release Press release | 23 March 2023 Tuberculosis India MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend monopoly on lifesaving TB drug 4 min
Photo credit: MSF/Alexandra Sadokova Press release Press release | 16 January 2023 Tuberculosis India India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline 4 min
Photograph by Oksana Parafeniuk Press release Press release | 15 December 2022 Tuberculosis MSF responds to groundbreaking updated WHO guidelines for drug-resistant tuberculosis 3 min
Photograph by Amelia Freelander Press release Press release | 03 May 2022 Tuberculosis MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multidrug-resistant TB 5 min
Photograph by Omar Rashid Research article Research article | 19 April 2022 Tuberculosis BMJ Global Health: Recently developed drugs for the treatment of drug-resistant tuberculosis: a research and development case study 2 min
Photograph by Atul Loke Press release Press release | 03 September 2021 Tuberculosis Lifesaving TB medicines must be affordable and available to make all-oral treatments for children a reality 4 min
Photograph by Atul Loke Press release Press release | 20 April 2021 Tuberculosis MSF supports TB survivors’ court case for Indian government to override patents on lifesaving TB drugs 7 min
